Search - tctmd.com

Displaying 1 - 20 of 56

Sort: Relevancy | Date

News Daily News

Top Heart Rhythm News of 2024

Todd Neale

December 27, 2024

News Daily News

Downsizing, Underexpansion Common in Redo TAVI With Sapien 3

Todd Neale

December 20, 2024

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Michael O'Riordan

November 27, 2024

News Conference News PCR London Valves 2024

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Michael O'Riordan

November 26, 2024

News Conference News VIVA 2024

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

L.A. McKeown

November 14, 2024

News Conference News TCT 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Yael L. Maxwell

November 07, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Presenter: Mahesh Madhavan

October 30, 2024

Presentation TCT 2024

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Presenter: Julien Ternacle

October 30, 2024

Presentation TCT 2024

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

Presenter: Philippe Pibarot

October 30, 2024

Presentation TCT 2024

Lessons Learned From the SMART Trial

Presenter: Howard Herrmann

October 30, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

TCT 638: Impact of Acute Hemodynamic Effects on Myocardial Remodeling and Mid-Term Durability After Transcatheter Edge-to-Edge Repair (TEER) of Mitral Regurgitation Using PASCAL®

Presenter: Tobias Geisler

October 28, 2024

Presentation TCT 2024

TCT 949: Long-term Mechanical Durability of Surgical Aortic Valves: A 2 Billion Cycle In Vitro Study

Presenter: Jae Hyun Jae

October 28, 2024

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Daily News

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Yael L. Maxwell

July 22, 2024

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

Advertisement

Top Heart Rhythm News of 2024

Downsizing, Underexpansion Common in Redo TAVI With Sapien 3

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

Lessons Learned From the SMART Trial

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

TCT 638: Impact of Acute Hemodynamic Effects on Myocardial Remodeling and Mid-Term Durability After Transcatheter Edge-to-Edge Repair (TEER) of Mitral Regurgitation Using PASCAL®

TCT 949: Long-term Mechanical Durability of Surgical Aortic Valves: A 2 Billion Cycle In Vitro Study

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content